HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-4.54%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$260M
AUM Growth
+$260M
(-3.5%)
Cap. Flow
+$7.99M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
25.84%
Holding
172
New
35
Increased
39
Reduced
27
Closed
24
Top Buys
| 1 |
Quanta Services
PWR
|
$2.06M |
| 2 |
Bausch Health
BHC
|
$2.03M |
| 3 |
Mastercard
MA
|
$2.03M |
| 4 |
3M
MMM
|
$1.98M |
| 5 |
MasTec
MTZ
|
$1.9M |
Top Sells
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$4.45M |
| 2 |
Amazon
AMZN
|
$2.95M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$2.23M |
| 4 |
Live Nation Entertainment
LYV
|
$2.02M |
| 5 |
Indivior
INDV
|
$1.83M |
Sector Composition
| 1 | Healthcare | 39.15% |
| 2 | Technology | 17.75% |
| 3 | Industrials | 8.61% |
| 4 | Consumer Discretionary | 6.17% |
| 5 | Financials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cytokinetics
CYTK
$5.98B
| $1.8M | 0.69% |
44,749
+30,488
| +214% | +$1.23M |
|
52
MoonLake Immunotherapeutics
MLTX
$3.78B
| $1.7M | 0.66% |
43,541
| – | – |
|
53
Cogent Biosciences
COGT
$1.83B
| $1.68M | 0.65% |
279,673
| – | – |
|
54
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $1.66M | 0.64% |
74,639
| – | – |
|
55
Booking.com
BKNG
$181B
| $1.64M | 0.63% |
357
-300
| -46% | -$1.38M |
|
56
Insmed
INSM
$30.3B
| $1.64M | 0.63% |
21,440
-6,172
| -22% | -$471K |
|
57
Immunovant
IMVT
$2.91B
| $1.63M | 0.63% |
+95,648
| New | +$1.63M |
|
58
NCR Atleos
NATL
$2.87B
| $1.63M | 0.63% |
+61,900
| New | +$1.63M |
|
59
Apogee Therapeutics
APGE
$2.27B
| $1.61M | 0.62% |
43,190
| – | – |
|
60
BridgeBio Pharma
BBIO
$9.91B
| $1.61M | 0.62% |
46,500
| – | – |
|
61
Avidity Biosciences
RNA
$6.12B
| $1.6M | 0.62% |
54,190
| – | – |
|
62
NVIDIA
NVDA
$4.15T
| $1.58M | 0.61% |
14,600
+3,700
| +34% | +$401K |
|
63
PTC
PTC
$25.4B
| $1.56M | 0.6% |
10,081
+1,300
| +15% | +$201K |
|
64
LKQ Corp
LKQ
$8.23B
| $1.56M | 0.6% |
+36,700
| New | +$1.56M |
|
|
TLN
65
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.54M | 0.59% |
7,700
+1,000
| +15% | +$200K |
|
66
Spyre Therapeutics
SYRE
$1.02B
| $1.54M | 0.59% |
95,159
| – | – |
|
67
Argan
AGX
$3.1B
| $1.53M | 0.59% |
+11,700
| New | +$1.53M |
|
68
Orthofix Medical
OFIX
$583M
| $1.52M | 0.58% |
92,900
+18,900
| +26% | +$308K |
|
69
Amphenol
APH
$135B
| $1.5M | 0.58% |
+22,900
| New | +$1.5M |
|
70
Praxis Precision Medicines
PRAX
$980M
| $1.49M | 0.57% |
39,286
+28,335
| +259% | +$1.07M |
|
71
TSMC
TSM
$1.2T
| $1.48M | 0.57% |
8,900
-2,200
| -20% | -$365K |
|
72
CNX Resources
CNX
$4.17B
| $1.47M | 0.57% |
+46,700
| New | +$1.47M |
|
73
CRH
CRH
$75.1B
| $1.47M | 0.57% |
+16,700
| New | +$1.47M |
|
74
Ciena
CIEN
$13.4B
| $1.47M | 0.57% |
24,300
+5,900
| +32% | +$357K |
|
75
Core Scientific
CORZ
$4.15B
| $1.44M | 0.56% |
199,100
+117,800
| +145% | +$853K |
|